On November 10, 2026, Curaleaf Holdings, Inc. ("Curaleaf") issued a statement confirming the company has received all required competition law clearances for proposed acquisition of Aurora Cannabis.
|
Curaleaf Holdings, Inc. is a medical and recreational marijuana dispensary operator in the United States. The company owns and operates dispensaries and cultivation sites, serving registered patients across multiple states including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International operates across Europe, Australasia, and North America. The company focuses on highly populated states and provides products through its retail network. Summarised from the company's own disclosures, fiscal year ended Oct 2026 |
Industry Specialty Retail | Homepage ir.curaleaf.com |
| Sector Consumer Cyclical | IR page ir.curaleaf.com | |
|
Tags
medical marijuana, recreational cannabis, dispensary operations, cannabis cultivation, patient services, Curaleaf International
|
Press page ir.curaleaf.com/press-releases |
Metrics
| Valuation | |
|---|---|
| Market cap | C$ 2.75B |
| Market cap (USD) | $ 1.922B |
| P/E | -60.05 |
| PEG | — |
| P/BV | — |
| P/S | 1.52 |
| P/OCF | 13.96 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -28.2% |
| ROI | -30.2% |
| ROIC | -30.2% |
| Profit margin | -18.0% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | — |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | No |
| Margin expanding | No |
| Buying back stock | — |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -66.7% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||
| Trade receivables (USD) | — | 60.4M | 52.2M | 55.7M | 64M | 73.9M |
| ↳ YoY growth | -13.7% | +6.7% | +15.0% | +15.4% | ||
| Borrowings, current (USD) | — | 1.97M | 52M | 39.5M | 102M | 35.7M |
| Borrowings, non-current (USD) | — | 458M | 571M | 548M | 467M | 513M |
| Lease liabilities (USD) | — | 193M | 309M | 296M | 285M | 278M |
| Cash and deposits (USD) | 73.5M | 299M | 163M | 91.8M | 107M | 102M |
| Intangible assets (USD) | — | 1.04B | 1.22B | 1.17B | 1.09B | 1.01B |
| Right-of-use assets (USD) | — | 76M | 123M | 118M | 117M | 113M |
| Net debt (borrowings + leases - cash) (USD) | — | 353M | 769M | 792M | 747M | 725M |
| Cash flow detail | ||||||
| Operating cash flow (USD) | — | -58.3M | 46.4M | 75.3M | 163M | 138M |
| Purchases of property, plant and equipment (USD) | — | -172M | -138M | -65.4M | -93.2M | -63.4M |
| Purchases of intangible assets (USD) | — | — | 0.00 | -4.86M | -5M | -1.21M |
| Change in receivables (cash effect) (USD) | — | -25.3M | 7.96M | -12.2M | -7.91M | -11M |
| Change in inventories (cash effect) (USD) | — | -93.1M | 31.2M | 9.85M | 2.99M | -3.72M |
| Change in payables (cash effect) (USD) | — | -10.3M | 51.7M | 2.23M | -5.63M | -5.2M |
| Interest paid (cash effect) (USD) | — | -33.4M | -78.8M | -97.9M | -96.4M | -104M |
| Income taxes paid (cash effect) (USD) | — | -91.8M | -156M | -100M | -16.5M | -27.1B |
| Share-based compensation (USD) | — | 39.5M | 28M | 20M | 25.7M | 35.7M |
| Operating cash flow before change in receivables (USD) | — | -33M | 38.4M | 87.5M | 170M | 149M |
| Free cash flow (OCF - PPE - intangibles) (USD) | — | -230M | -92M | 4.96M | 64.4M | 73.1M |
| Income detail | ||||||
| Research and development expense (USD) | — | — | — | — | 1.42M | 805,000 |
| Total comprehensive income (USD) | — | -225M | -394M | -279M | -235M | -201M |
| Comprehensive income to owners (USD) | — | -213M | -382M | -274M | -224M | -213M |
| Provision for credit losses (USD) | — | -4.58M | -12M | 7.54M | 276,000 | 977,000 |
| Credit cost ratio (credit losses / average receivables) (%) | — | — | 21.3% | 14.0% | 0.5% | 1.4% |
| Reported | May 2, 2023 | May 2, 2023 | Mar 7, 2024 | Mar 7, 2024 | Feb 27, 2026 | Feb 27, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpPress releases from the company's own website, newest first. Material events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR.
On November 3, 2026, Curaleaf Holdings, Inc. ("Curaleaf") issued a statement regarding the alternative proposal for Aurora Cannabis. A copy of the press release is attached as Exhibit 99.1.
Third quarter 2026 net revenue of $353 million
Third quarter 2026 International revenue of $59 million
Third quarter 2026 adjusted gross profit margin of 49%
Third quarter adjusted EBITDA of $78 million
Stamford, Conn., November 03, 2026 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer and medical cannabis products, today reported its financial and operating results for the third quarter ended September 30, 2026. All financial information is reported in accordance with U.S. generally accepted accounting principles (“U.S. GAAP” or “GAAP”) and is provided in U.S. dollars unless otherwise indicated.
Chairman and CEO Boris Jordan said, “We are building the global leader in cannabis, and our third-quarter results provide further evidence that our strategy is delivering. Solid execution across the business is driving growth, strengthening our competitive position, and advancing our Built for Growth plan. Against a backdrop of increasing pressure on the consumer, cannabis demand remained resilient and our business delivered strong, broad-based growth.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Curaleaf Holdings, Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.




